MedTrace Logo

Neurocognitive Effects of Meal Timing in a One-Meal-a-Day Regimen

NCT07181057 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-09-18

No results posted yet for this study

Summary

Objectives: The purpose of this study is to examine how meal timing in a one-meal-a-day (OMAD) regimen influences neurocognitive outcomes.

Methods: Twelve cognitively active participants (academics, students, software engineers) will complete three randomized OMAD conditions, consuming a standardized isocaloric meal at 08:00, 12:30, or 18:00. ERPs will be recorded during a computerized Stroop task to evaluate peak amplitudes and latencies under congruent and incongruent conditions. Resting-state EEG will be measured under eyes-open and eyes-closed conditions. Behavioral performance on the Stroop task, including reaction time and accuracy, will also be assessed.

Conditions

  • Fasting State
  • Cognitive Abilities

Interventions

OTHER

one-meal-a-day (OMAD)

Arm Title: Morning Meal (08:00) Intervention: Other: One-meal-a-day (OMAD) Description: Participants consume a single isocaloric meal at 08:00. Arm Title: Midday Meal (12:30) Intervention: Other: One-meal-a-day (OMAD) Description: Participants consume a single isocaloric meal at 12:30. Arm Title: Evening Meal (18:00) Intervention: Other: One-meal-a-day (OMAD) Description: Participants consume a single isocaloric meal at 18:00.

Sponsors & Collaborators

  • Erzurum Technical University

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2025-05-01
Completion
2025-05-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07181057 on ClinicalTrials.gov